Literature DB >> 1341685

Postnatal cerebral maturation in Down's syndrome children: a developmental EEG coherence study.

R McAlaster1.   

Abstract

Eyes-closed EEG was recorded from 19 scalp locations in thirty Down's Syndrome children and young adults, aged 9 months to 26 years. These subjects were age-matched to normal children and normal young adults. EEG coherence was computed for five groups of electrode pairings: 1--anterior-to-posterior, 2--posterior-to-anterior, 3--posterior temporal, 4--anterior temporal and 5--interhemispheric. The results showed that EEG coherence strongly and consistently discriminated between the two groups. Developmental trajectories in the Down's group were weakly linear and often with negative slopes. In contrast, normal children showed strong linear and nonlinear developmental trajectories with only positive slopes. The greatest differences between groups was in the left hemisphere and in posterior cortical regions as compared to frontal regions. The normal children exhibited growth spurts in EEG coherence at particular postnatal ages, whereas the Down's Syndrome children failed to exhibit strong growth spurts in EEG development.

Entities:  

Mesh:

Year:  1992        PMID: 1341685     DOI: 10.3109/00207459209003296

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  3 in total

1.  EEG coherence and reference signals: experimental results and mathematical explanations.

Authors:  M Essl; P Rappelsberger
Journal:  Med Biol Eng Comput       Date:  1998-07       Impact factor: 2.602

2.  Development of cortical connections as measured by EEG coherence and phase delays.

Authors:  Robert W Thatcher; Duane M North; Carl J Biver
Journal:  Hum Brain Mapp       Date:  2008-12       Impact factor: 5.038

3.  Self-organized criticality and the development of EEG phase reset.

Authors:  Robert Wayne Thatcher; Duane Michael North; Carl John Biver
Journal:  Hum Brain Mapp       Date:  2009-02       Impact factor: 5.038

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.